Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph F Murphy

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical Medicine Insights. Oncology|August 13, 2010
Trends in cancer immunotherapyJoseph F Murphy
British Journal of Haematology|February 18, 2003
A peptide (P2) derived from the variable heavy chain of an anti-P-selectin monoclonal antibody (LYP20) inhibits leucocyte adhesion to thrombin-activated platelets and endothelial cellsJoseph F Murphy, John L McGregor
Science (New York, N.Y.)|May 23, 2009
Robot inventors: patently impossible?Robert W Stevenson, Joseph F Murphy, Thomas J Clare
British Journal of Haematology|April 3, 2003
Induction of cyclooxygenase-1 and -2 modulates angiogenic responses to engagement of alphavbeta3Joseph F Murphy, Christopher Steele, Orina Belton, et al.
Expert Review of Clinical Immunology|August 11, 2017
Immunotherapy of cancers comes of ageHila Yousefi, Jianda Yuan, Mahsa Keshavarz-Fathi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 11, 2005
Engagement of CD44 modulates cyclooxygenase induction, VEGF generation, and proliferation in human vascular endothelial cellsJoseph F Murphy, Frances Lennon, Christopher Steele, et al.
Pancreas|February 2, 2010
Vascular endothelial growth factor and not cyclooxygenase 2 promotes endothelial cell viability in the pancreatic tumor microenvironmentDesmond P Toomey, Ellen Manahan, Ciara McKeown, et al.
Journal for Immunotherapy of Cancer|July 6, 2019
Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshopDavide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, et al.
Journal for Immunotherapy of Cancer|May 23, 2019
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshopDavide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Medicine Insights. Oncology|August 13, 2010
Trends in cancer immunotherapyJoseph F Murphy
British Journal of Haematology|February 18, 2003
A peptide (P2) derived from the variable heavy chain of an anti-P-selectin monoclonal antibody (LYP20) inhibits leucocyte adhesion to thrombin-activated platelets and endothelial cellsJoseph F Murphy, John L McGregor
Science (New York, N.Y.)|May 23, 2009
Robot inventors: patently impossible?Robert W Stevenson, Joseph F Murphy, Thomas J Clare
British Journal of Haematology|April 3, 2003
Induction of cyclooxygenase-1 and -2 modulates angiogenic responses to engagement of alphavbeta3Joseph F Murphy, Christopher Steele, Orina Belton, et al.
Expert Review of Clinical Immunology|August 11, 2017
Immunotherapy of cancers comes of ageHila Yousefi, Jianda Yuan, Mahsa Keshavarz-Fathi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 11, 2005
Engagement of CD44 modulates cyclooxygenase induction, VEGF generation, and proliferation in human vascular endothelial cellsJoseph F Murphy, Frances Lennon, Christopher Steele, et al.
Pancreas|February 2, 2010
Vascular endothelial growth factor and not cyclooxygenase 2 promotes endothelial cell viability in the pancreatic tumor microenvironmentDesmond P Toomey, Ellen Manahan, Ciara McKeown, et al.
Journal for Immunotherapy of Cancer|July 6, 2019
Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshopDavide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, et al.
Journal for Immunotherapy of Cancer|May 23, 2019
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshopDavide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, et al.
Pageof 1